Viral genetic determinants of h5n1 influenza viruses that contribute to cytokine dysregulation by Chan, MC et al.
Title Viral genetic determinants of h5n1 influenza viruses thatcontribute to cytokine dysregulation
Author(s) Mok, KP; Wong, CHK; Cheung, CY; Chan, MC; Lee, SMY;Nicholls, JM; Guan, Y; Peiris, JSM
Citation Journal Of Infectious Diseases, 2009, v. 200 n. 7, p. 1104-1112
Issued Date 2009
URL http://hdl.handle.net/10722/78991
Rights Creative Commons: Attribution 3.0 Hong Kong License
1104 • JID 2009:200 (1 October) • Mok et al
M A J O R A R T I C L E
Viral Genetic Determinants of H5N1 Influenza
Viruses That Contribute to Cytokine Dysregulation
Ka Pun Mok,1,a Charmaine H. K. Wong,1,a Chung Y. Cheung,1 Michael C. Chan,1 Suki M. Y. Lee,1 John M. Nicholls,2
Yi Guan,1 and Joseph S. M. Peiris1,3
Departments of 1Microbiology and 2Pathology, Li Ka Shing Faculty of Medicine, University of Hong Kong, and 3HKU-Pasteur Research Centre,
Pok Fu Lam, Hong Kong Special Administrative Region, People’s Republic of China
Human disease caused by highly pathogenic avian influenza (H5N1) is associated with fulminant viral pneu-
monia and mortality rates in excess of 60%. Cytokine dysregulation is thought to contribute to its pathogenesis.
In comparison with human seasonal influenza (H1N1) viruses, clade 1, 2.1, and 2.2 H5N1 viruses induced
higher levels of tumor necrosis factor–a in primary human macrophages. To understand viral genetic deter-
minants responsible for this hyperinduction of cytokines, we constructed recombinant viruses containing
different combinations of genes from high-cytokine (A/Vietnam/1203/04) and low-cytokine (A/WSN/33) phe-
notype H1N1 viruses and tested their cytokine-inducing phenotype in human macrophages. Our results suggest
that the H5N1 polymerase gene segments, and to a lesser extent the NS gene segment, contribute to cytokine
hyperinduction in human macrophages and that a putative H5 pandemic virus that may arise through genetic
reassortment between H5N1 and one of the current seasonal influenza viruses may have a markedly altered
cytokine phenotype.
Highly pathogenic avian influenza H5N1 viruses have
affected poultry and other birds in 160 countries across
3 continents. They have been transmitted zoonotically
to humans in 15 countries, causing human disease with
an overall mortality rate of 160% and continuing to
pose a pandemic threat. Since their first detection in
1996, these highly pathogenic avian influenza H5N1
viruses have continued to reassort and evolve, giving
rise to a number of virus genotypes and clades [1].
Human disease has been caused by Z-genotype viruses
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of clade 1 in Thailand, Vietnam, and Cambodia, clade
2.1 in Indonesia, and clade 2.2 in the Middle East and
Africa. More recently, clade 2.3.4 viruses of the V ge-
notype have become dominant in China and North
Vietnam, causing human disease in these countries. Al-
though virus dissemination beyond the human respi-
ratory tract does occur and sometimes contributes to
disease severity, lung pathology remains the major cause
of death. Studies in vitro and in vivo have indicated
that high viral replication and cytokine dysregulation,
and perhaps tissue tropism, are factors contributing to
lung pathology [2]. The key target cells for the virus
in the lung are the alveolar epithelial cells and mac-
rophages [3]. We and others have shown elsewhere that
primary human macrophages and alveolar epithelial
cells infected with H5N1 viruses secrete markedly
higher levels of proinflammatory cytokines and che-
mokines than do those infected with human H1N1 or
H3N2 viruses [4–6] and that the interplay of such me-
diator interactions between macrophages and alveolar
epithelial cells amplifies this inflammatory cascade [7].
So far, only a limited number of recent H5N1 viruses
of clade 0 and clade 1 have been tested for their cytokine
phenotype [4–6, 8, 9]. More importantly, the virus ge-
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Table 1. Wild-Type Influenza Viruses Used in This Study
Virus Subtype Abbreviation H5N1 clade (genotype) Country of origin Passage history
A/Hong Kong/54/98 (H1N1) H1N1 54/98 (H1N1) … Hong Kong MDCK  7
A/Hong Kong/178394/04 (H1N1) H1N1 178394/04 (H1N1) … Hong Kong MDCK  3
A/Hong Kong/87856/05 (H1N1) H1N1 87856/05 (H1N1) … Hong Kong MDCK  3
A/Hong Kong/82965/05 (H1N1) H1N1 829165 (H1N1) … Hong Kong MDCK  3
A/goose/Hong Kong/437.6/99 (H5N1)a H5N1 437.6/99 (H5N1) 0 Hong Kong Egg  4
A/Hong Kong/483/97 (H5N1) H5N1 483/97 (H5N1) 0 Hong Kong MDCK  8
A/chicken/Indonesia/BL/03 (H5N1) H5N1 BL/03 (H5N1) 2.1 (Z) Indonesia MDCK  6
A/chicken/Indonesia/2A/04 (H5N1) H5N1 2A/04 (H5N1) 2.1 (Z) Indonesia MDCK  4
A/chicken/Thailand/AIV-1/04 (H5N1) H5N1 AIV-1/04 (H5N1) 1 (Z) Thailand Egg  3; MDCK  4
A/chicken/Vietnam/33/04 (H5N1) H5N1 33/04 (H5N1) 1 (Z) Vietnam Egg  3; MDCK  3
A/Vietnam/1203/04 (H5N1) H5N1 1203/04 (H5N1) 1 (Z) Vietnam MDCK  4
A/Vietnam/1194/04 (H5N1) H5N1 1194/04 (H5N1) 1 (Z) Vietnam MDCK  6
A/Thailand/MK2/04 (H5N1) H5N1 MK2/04 (H5N1) 1 (Z) Vietnam MDCK  4
A/Vietnam/3046/04 (H5N1) H5N1 3046/04 (H5N1) 1 (Z) Vietnam MDCK  4
A/bar-headed goose/Qinghai/5/05 (H5N1) H5N1 QH5/05 (H5N1) 2.2 (Z) China MDCK  1
NOTE. MDCK, Madin-Darby canine kidney.
a A/goose/Hong Kong/437.6/99 (H5N1) is from a A/goose/Guangdong/1/96 (H5N1)–like lineage.
netic determinants responsible for activating this cytokine
hyperinduction remain obscure. Other studies have suggested
that although the NS gene segment of the H5N1 virus may
contribute modestly to the high-cytokine phenotype, it is not
the major viral genetic determinant. In this study, we dem-
onstrate that the H5N1 polymerases, rather than viral hem-
agglutinin (HA) and neuraminidase (NA), are the major viral
genetic determinants of the cytokine dysregulation induced by
H5N1 viruses in primary human macrophages.
METHODS
Viruses. The abbreviations, origins, and passage history of all
the wild-type virus strains used in this study are shown in table
1. Virus infectivity was assessed by titration in Madin-Dar-
by canine kidney (MDCK) cells. All procedures involving live
H5N1 viruses and recombinant viruses were carried out in a
biosafety level 3 facility.
Isolation of primary human macrophages and primary type
I–like pneumocytes. Blood mononuclear cells from healthy
donors (Hong Kong Red Cross Blood Transfusion Service) were
separated by Ficoll-Paque centrifugation, and monocytes were
purified by the adherence method and differentiated into mac-
rophages, as described elsewhere [4]. Primary human type I–
like pneumocytes were isolated from nontumor lung tissues
using methods described elsewhere [5].
Infection of macrophages and pneumocytes. Primary mac-
rophages and type I–like pneumocytes were seeded at 51 10
cells per well in 24-well tissue-culture plates. The cells were
infected at a multiplicity of infection of 2 unless otherwise
indicated. After 30 min of virus adsorption, the virus inoculum
was removed, and the cells were washed with phosphate-buf-
fered saline and incubated in warm culture medium (serum-
free medium for macrophages [GIBCO] and small airway
growth medium for pneumocytes [Cambrex BioScience]) sup-
plemented with 0.6 mg/L penicillin, 60 mg/L streptomycin, and
1 mg/L N-p-tosyl-l-phenylalanine chloromethyl ketone–treated
trypsin (Sigma). Samples of culture supernatant were collected
for virus titration and cytokine analysis. RNA was extracted
from cells for analysis of cytokine gene expression. To confirm
that the cells were all infected, they were fixed at 8 h after in-
fection and analyzed by immunofluorescent staining specific
for influenza virus nucleoprotein and matrix proteins (Dako
Imagen; Dako Diagnostics).
Quantification of cytokine messenger RNA by real-time
reverse-transcription polymerase chain reaction (PCR).
DNase-treated total RNA was isolated using the RNeasy Mini
kit (Qiagen). The complementary DNA (cDNA) was synthe-
sized from messenger RNA (mRNA) with poly(dT) primers
and SuperScript II reverse transcriptase (Life Technologies).
Transcript expression was determined using TaqMan Fast Uni-
versal Master Mix kit (Applied Biosystems) with specific prim-
ers. The fluorescence signals were measured by ABI Prism 7500
Sequence Detection System. The gene copy number of the tar-
get gene was normalized to the b-actin control and compared
with the results of known amounts of plasmid encoding the
target gene sequence. The results were presented as copy num-
bers of target genes per copies of b-actin control.51 10
Quantitative analysis of tumor necrosis factor (TNF)–a by
enzyme-linked immunosorbent assay in cell culture super-
natants. The cell culture supernatants were collected at 6 h
after infection and were irradiated with ultraviolet light (CL-
100 ultraviolet crosslinker; UVP) for 15 min to inactivate the
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Figure 1. Tumor necrosis factor (TNF)–a secreted by primary human macrophages infected with H5N1 viruses of different clades and genotypes
and H1N1 viruses (A) or recombinant H1N1 viruses containing NS gene segments of H5N1 viruses (B). Primary human macrophages were infected
by H5N1 or H1N1 viruses at a multiplicity of infection of 2, and the amount of TNF-a released into the supernatant was quantified by enzyme-linked
immunosorbent assay at 3 (gray), 8 (white), and 24 h (black) after infection. Error bars indicate standard deviations calculated from the results of 3
independent experiments that used macrophages from different donors. Mock, uninfected cells. A, Macrophages infected with H5N1 viruses of clades
0, 1, 2.1, and 2.2 and different H1N1 viruses. Virus abbreviations are shown in table 1. B, Macrophages similarly infected with recombinant H1N1
(A/WSN/33) viruses with NS gene segments of different H5N1 viruses and the relevant precursor wild-type controls. Virus abbreviations are shown
in table 2.
virus before the levels of TNF-a were measured by a specific
TNF-a assay kit (R&D Systems), as described elsewhere [4].
Virus titration. The amount of virus in the supernatants
of the influenza virus–infected macrophage cultures was titrated
on MDCK cells, and the titers were reported as median tissue
culture infective dose units per 100 mL (TCID50/100 mL).
Plasmid construction and reverse genetics. Recombinant
viruses were generated by Reverse Genetics [10, 11]. The cDNAs
of the A/Vietnam/1203/04 (H5N1) and A/WSN/33 (H1N1)
strains were first synthesized by reverse transcription of viral
RNA with an oligonucleotide (Uni-12) complementary to the
conserved 3’ end of the viral RNA. The cDNA was then am-
plified by PCR with gene-specific primers. The reverse-tran-
scription PCR products of viral RNA segments were cloned
into the plasmid pHW2000. The newly introduced viral RNA
in the recombinant viruses was sequenced for further confir-
mation. The mutant PB2 construct containing a mutation with
amino acid at position 627 (1203[PB2-K627E]) was produced
by PCR amplification with the primers possessing the mutation.
Statistical analysis. The statistical significance of differ-
ences between experimental groups was determined by using
the unpaired, nonparametric Student’s t test. Correlation be-
tween experimental groups was determined by using the Spear-
man nonparametric test. For both tests, differences were con-
sidered significant at .P ! .05
RESULTS
TNF-a induction in human macrophages infected by different
clades of H5N1 viruses. Our previous studies showed that
some H5N1 viruses isolated from 1997 through 2003 induced
a high proinflammatory cytokine response in primary human
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Table 2. Recombinant Influenza Viruses Used in This Study
Recombinant virus Virus used as background
Viral segments or point mutations
substituted in the background
WSN A/WSN/33 (H1N1) …
WSN (483-NS) A/WSN/33 (H1N1) NS; A/Hong Kong/483/97 (H5N1)
WSN (BL-NS) A/WSN/33 (H1N1) NS; A/chicken/Indonesia/BL/03 (H5N1)
WSN (AIV-NS) A/WSN/33 (H1N1) NS; A/chicken/Thailand/AIV-1/04 (H5N1)
WSN (1194-NS) A/WSN/33 (H1N1) NS; A/Vietnam/1194/04 (H5N1)
WSN (1203-NS) A/WSN/33 (H1N1) NS; A/Vietnam/1203/04 (H5N1)
WSN (1203-HN) A/WSN/33 (H1N1) HA, NA; A/Vietnam/1203/04 (H5N1)
WSN (1203-HNP1) A/WSN/33 (H1N1) HA, NA, PB1; A/Vietnam/1203/04 (H5N1)
WSN (1203-3P) A/WSN/33 (H1N1) PA, PB1, PB2; A/Vietnam/1203/04 (H5N1)
WSN (1203-PB2) A/WSN/33 (H1N1) PB2; A/Vietnam/1203/04 (H5N1)
1203 A/Vietnam/1203/04 (H5N1) …
1203 (WSN-PB2) A/Vietnam/1203/04 (H5N1) PB2; A/WSN/33 (H1N1)
1203 (WSN-3P) A/Vietnam/1203/04 (H5N1) PA, PB1, PB2; A/WSN/33 (H1N1)
1203 (PB2-K627E) A/Vietnam/1203/04 (H5N1) PB2 residue at position 627 changed
from lysine to glutamic acid
PR8 A/PR/8/34 (H1N1) …
PR8 (1203-HNP1) A/PR/8/34 (H1N1) HA, NA, PB1; A/Vietnam/1203/04 (H5N1)
NOTE. HA, hemagglutinin; NA, neuraminidase.
macrophages and in infected humans [4, 7, 12]. To extend these
findings to more recent clade 1, 2.1, and 2.2 viruses of the Z-
genotype viruses isolated in 2004 and 2005, we compared vi-
ruses isolated from humans and poultry from 2004 through
2005 with the H5N1 virus isolated from humans in 1997
(H5N1/97). Human seasonal H1N1 influenza viruses and a
virus representing the parental A/Gs/Gd/96-like H5N1 lineage
(A/Gs/HK/437.6/99) were used for comparison. The viruses
used are listed in table 1.
Primary human macrophages were infected at a multiplicity
of infection of 2, and the level of TNF-a secreted in the su-
pernatant was quantified at 3, 8, and 24 h after infection with
use of an enzyme-linked immunosorbent assay (figure 1A).
These H5N1 viruses induced varying levels of TNF-a, but they
all induced higher levels of TNF-a than did H1N1 viruses
(figure 1A). In particular, the H5N1 viruses isolated from 2
human subjects with fatal cases, 1194/04 and 1203/04, as well
as the viruses isolated from chickens, BL/03 and AIV-1/04,
induced 2-fold greater TNF-a levels than did H5N1 483/97.
The levels of mRNA expression were consistent with results of
the protein assays (data not shown). Our results suggest that,
in comparison with a range of human H1N1 viruses, human
and poultry Z-genotype viruses of clades 1, 2.1, and 2.2 isolated
in 2004 and 2005 are all potent hyperinducers of cytokines such
as TNF-a, possibly even more potent than H5N1 483/97.
Contribution by H5N1 NS proteins and polymerases but
not surface proteins to high-cytokine phenotype. We have
shown elsewhere that recombinant A/WSN/33 (WSN) influ-
enza containing the NS gene segment of H5N1/97 virus is a
more potent inducer of TNF-a than the WSN H1N1 parent,
although such a recombinant virus did not fully regain the
high-cytokine phenotype manifested by the H5N1 virus parent
[4]. Because the internal genes (including the NS gene) of the
contemporary Z-genotype H5N1 viruses have different evo-
lutionary derivations compared with H5N1/97, we investigated
whether the NS gene segment of contemporary Z-genotype
viruses also contributes to the high-cytokine phenotype. Re-
combinant viruses carrying the NS gene segment of the H5N1
viruses A/Hong Kong/483/97, A/chicken/Indonesia/BL/03, A/
chicken/Thailand/AIV-1/04, A/Vietnam/1194/04, or A/Vietnam/
1203/04 were constructed in a background of WSN (H1N1)
virus, which is a low cytokine inducer, and a plasmid-derived
WSN wild-type virus was used as control. At 8 h after infec-
tion, the recombinant viruses produced higher concentrations
of TNF-a than did the WSN control virus (figure 1B). How-
ever, as with the data reported elsewhere for the H5N1/97 vi-
rus [4], although each of the NS genes of Z-genotype H5N1
viruses increased the level of TNF-a induction compared with
the parental WSN virus, the level of induction in each case was
far below that induced with the wild-type H5N1 virus. We
therefore concluded that the increase in TNF-a produced by
Z-genotype H5N1 viruses is only partly attributable to the
H5N1 NS gene segment.
To determine the major viral genetic determinants of Z-
genotype viruses that mediate the high–TNF-a phenotype, re-
combinant viruses were constructed that contained different
combinations of a H5N1 virus A/Vietnam/1203/04 (1203) gene
segments in a background of a H1N1 virus A/WSN/33 (WSN)
(table 2). We investigated whether the surface proteins (HA or
NA) or the polymerase genes and gene products are key factors
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Figure 2. H5N1 polymerase genes contribute to hyperinduction of cy-
tokine gene expression, but H5N1 surface proteins do not. Primary human
macrophages were infected by recombinant viruses WSN or 1203 or the
1203 polymerase gene/surface protein–reassortant virus at a multiplici-
ty of infection of 2. A, Tumor necrosis factor (TNF)–a released into the
supernatant was quantified by enzyme-linked immunosorbent assay at 6
h after infection. The messenger RNA (mRNA) of the samples was col-
lected at 3 h after infection. The copy numbers of TNF-a (B), interferon
(IFN)–inducible protein (IP-10) (C), and IFN-b (D) mRNA were analyzed by
Taqman real-time reverse-transcription polymerase chain reaction. Values
were normalized by the copy numbers of b-actin gene and statistically
analyzed by 2-tailed, paired t test. Mock, uninfected cells. * .P ! .05
that mediate the induction of high levels of TNF-a. The TNF-
a levels induced in primary human macrophages infected by
these recombinant viruses were tested (figure 2A and 2B), and
the data are summarized in table 3. Recombinant virus carrying
the H5N1-1203 surface proteins HA and NA in a WSN back-
ground, WSN(1203-HN), produced low levels of TNF-a in
human macrophages, comparable to levels produced by the
WSN control virus. Moreover, the WSN(1203-HNP1) virus,
which carries HA, NA, and PB1 gene segments from Z-genotype
H5N1, also did not induce high levels of TNF-a. We have
independently confirmed these findings with use of a recom-
binant A/PR/8/34 (H1N1) virus (low-cytokine phenotype) con-
taining 1203-HA, NA, and PB1 (data not shown).
WSN virus carrying the 3 polymerase gene segments of H5N1
(WSN[1203-3P]) was a strong inducer of TNF-a, comparable
to the H5N1 virus itself (figure 2A and table 3). A reverse gene
exchange (1203[WSN-3P]) virus was also a high TNF-a in-
ducer (data not shown). H5N1 1203/04 PB2 in a WSN back-
ground (WSN[1203-PB2]) had low TNF-a induction (10.4%
of that with the 1203 virus) (table 3), whereas a virus that
carried the WSN PB2 gene segment in a H5N1 background
(1203[WSN-PB2]) had moderate TNF-a induction (40.9% of
that with the 1203 virus) (table 3). These findings were par-
alleled by TNF-a mRNA levels (figure 2B).
Other studies have shown that the lysine at position 627 in
the H5N1 PB2 residue determines the high virulence of H5N1
viruses in the in vivo mouse model [13]. To understand whether
cytokine induction was affected by this amino acid substitution,
primary human macrophages were infected with recombinant
1203/04 virus with and without a single change at PB2 627
residue from lysine to glutamic acid (1203[PB2-K627E]). Sur-
prisingly, the TNF-a protein level decreased 170%, suggesting
that this amino acid residue in the H5N1 1203 PB2 gene is
essential for cytokine hyperinduction within the context of the
1203 H5N1 gene constellation.
Because we showed elsewhere that H5N1/97 hyperinduces
chemokines and interferons (IFNs) in addition to TNF-a in
virus-infected human macrophages, we further examined IFN-
induced protein (IP-10; chemokine [C-X-C motif] ligand 10)
and IFN-b mRNA levels in human macrophages infected with
the recombinant virus panel [4]. We found that the induction
profile of these 2 cytokines showed a pattern similar to that
seen with TNF-a (figure 2C and 2D). These results suggest that
the polymerases of H5N1 control not only TNF-a induction
but also the induction of other proinflammatory chemokines
and IFN.
We have shown elsewhere that H5N1 viruses also manifest
a high-cytokine phenotype when infecting primary human lung
pneumocytes but do not directly induce TNF-a [5]. Here we
tested whether this hyperinduction can be perturbed using
H5N1 viruses with a mutation from lysine to glutamic acid at
position 627 in the PB2 gene segment. Primary human type
1–like pneumocytes were infected with 1203(PB2-K627E), 1203/
04, and WSN/33 viruses under the same conditions used for
the human macrophage infection experiments. IP-10 and IFN-
b transcription decreased significantly in 1203(PB2-K627E)-
infected pneumocytes, compared with those infected with the
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Table 3. Contribution of 1203/04 Gene Segments to Tumor Necrosis Factor (TNF)–a Induction in Human Macrophages
Recombinant virus
Virus segment
TNF-a induction,
compared with 1203/04, %HA NA PB1 PB2 PA NS NP M
WSN WSN WSN WSN WSN WSN WSN WSN WSN 11.0
WSN (1203-HN) H5N1 H5N1 WSN WSN WSN WSN WSN WSN 11.4
WSN (1203-HNP1) H5N1 H5N1 H5N1 WSN WSN WSN WSN WSN 8.4
WSN (1203-3P) WSN WSN H5N1 H5N1 H5N1 WSN WSN WSN 55.1
WSN (1203-PB2) WSN WSN WSN H5N1 WSN WSN WSN WSN 10.4
1203 H5N1 H5N1 H5N1 H5N1 H5N1 H5N1 H5N1 H5N1 100.0
1203 (WSN-PB2) H5N1 H5N1 H5N1 WSN H5N1 H5N1 H5N1 H5N1 40.9
1203(PB-2K627E) H5N1 H5N1 H5N1 H5N1a H5N1 H5N1 H5N1 H5N1 16.0
NOTE. HA, hemagglutinin; NA, neuraminidase.
a Glutamic acid at position 627 of PB2.
Figure 3. Lysine at position 627 of H5N1 PB2 affects cytokine gene expression in primary human pneumocytes. Primary human pneumocytes were
infected by recombinant viruses WSN, 1203, or 1203(PB2-K627E) at a multiplicity of infection of 2. The messenger RNA (mRNA) of the samples was
collected at 3, 6, and 12 h after infection. The copy numbers of interferon (IFN)–inducible protein (IP-10) (A) and IFN-b (B) mRNA were analyzed by
Taqman real-time reverse-transcription polymerase chain reaction. Values were normalized by the copy numbers of b-actin gene and statistically
analyzed by 2 tailed, paired t test. Mock, uninfected cells. * .P ! .05
1203/04 control virus (figure 3). This showed that the hyper-
induction of cytokine in human pneumocytes is also regulated
by the lysine at PB2 627 in H5N1 virus.
Replication of influenza viruses in human macrophages.
We next investigated whether the difference in cytokine in-
duction is simply a manifestation of increased virus replication
competence in primary human macrophages. Viral replication
competence, as quantified by M gene virus load 3 h after in-
fection, was correlated with TNF-a protein levels at 6–8 h after
infection. When low- and high-cytokine phenotype viruses (ie,
H5N1 and H1N1) were considered together, there was no cor-
relation between M gene copy numbers and TNF-a levels
( , by Spearman test). However, among the high-cyto-Pp .34
kine phenotype wild-type viruses (highly pathogenic avian in-
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Figure 4. Viral messenger RNA (mRNA) transcription and infectious virus yield of the recombinant viruses. Primary human macrophages were
infected by recombinant viruses WSN or 1203 or the 1203 polymerase gene/surface protein–reassortant virus at a multiplicity of infection of 2. A,
Levels of matrix protein mRNA (M gene) at 3 and 6 h after infection were quantified by Taqman real-time reverse-transcription polymerase chain
reaction. B, Primary human macrophages were infected by the recombinant viruses at an multiplicity of infection of 0.01. Median tissue culture
infective dose (TCID50) of samples at 24 h after infection were determined by titration on Madin-Darby canine kidney cells. Mock, uninfected cells.
fluenza H5N1, excluding 437.6/99, which is a low-cytokine
H5N1 precursor), there was a positive correlation between viral
M gene copies and TNF-a levels (figure 1A) ( , by Spear-P ! .05
man test). There was a similar positive correlation between M
gene levels and TNF-a levels within the WSN-H5N1 1203 re-
combinant viruses (figures 2A and 4A) ( , by SpearmanP ! .05
test). However, although the viral M gene copies and TCID50
titers of 1203(PB2-K627E) virus were similar to those of wild-
type 1203 recombinant control virus (figure 4A and 4B), cy-
tokine induction was significantly reduced (figure 2A), sug-
gesting that glutamic acid at position 627 of H5N1 PB2 virus
enhances cytokine induction by a mechanism other than al-
teration of virus replication competence.
DISCUSSION
We and others have shown elsewhere that H5N1/97 viruses and
those of the Z genotype associated with the more recent out-
breaks of disease in poultry and humans have a high-cytokine
phenotype in primary human macrophages [4, 6]. However,
not all H5N1 viruses isolated during the past 14 years have the
same phenotype. For example, viruses of the precursor A/goose/
Guangdong/1/96 H5N1 virus genotype and those of genotype
B, which do not share the same constellation of virus internal
genes, also do not share this property of high cytokine induction
[8]. In this study, we have shown that clade 1, 2.1, and 2.2
H5N1 viruses of Z genotype, isolated from 2004 through 2005
from humans or from birds, retain the high-cytokine phenotype
in virus-infected primary human macrophages. The cytokine
phenotype of the V-genotype viruses that predominated in
southern China since 2005 [14] and in North Vietnam and
Laos in 2006–2007 [15] have not yet been investigated. These
V-genotype viruses differ from Z-genotype viruses only in their
PA genes.
Because previous data have suggested that cytokine dysregu-
lation is a contributory factor in H5N1-related disease path-
ogenesis, our results may reflect one aspect of the virulence of
the Z-genotype viruses in humans [4, 5, 8, 12, 16]. We have
demonstrated that the virus polymerase complex and, to a lesser
extent, the NS gene segment of H5N1 are 2 viral genetic de-
terminants that contribute to cytokine hyperinduction. Al-
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though the genetic background of the internal genes in H5N1/
97 and Z-genotype viruses are different, we showed that NS
genes of both viruses help contribute to the cytokine hyper-
induction. The NS1 protein generated from the NS gene is
known to play a role in the inhibition of type I IFN and IFN-
induced proteins, such as double-stranded RNA–dependent
protein kinase R and 2′5′-oligoadenylate synthetase/RNase L
during infection [17–19]. In addition, it has been shown that
the hyperinduction of TNF-a in H5N1-infected primary hu-
man macrophages is partly regulated by the activation of p38
kinase [20]. It remains to be investigated whether the NS gene
of H5N1 viruses is responsible for activating p38 (either direct-
ly or through lack of inhibition), leading to the induction of
TNF-a in primary human macrophages.
The PB2 gene and, to a lesser extent, the HA gene have been
identified as contributing to the virulence of H5N1 viruses in
mice [21]. Our in vitro study showed that the HA gene of
H5N1 does not by itself regulate cytokine induction in human
macrophages. However, it may well contribute to virus viru-
lence in other ways, for example, by promoting virus dissem-
ination beyond the respiratory tract.
It is of interest that the virulence of the 1203/04 virus in
ferrets was determined by the polymerase complex and, to a
lesser extent, the NS gene segment [22]. These results are con-
cordant with our findings that the polymerase complex genes
from H5N1 virus are needed to induce high levels of cytokine
(WSN[1203-3P]). The mechanism by which the polymerase
gene complex determines cytokine hyperinduction is still not
known. Our findings suggest that the synergistic functionality
of the homologous polymerase gene complex is important for
the high-cytokine phenotype. WSN (H1N1) virus carrying the
PB2, PB1, and PA gene segments of 1203 (H5N1) virus manifest
a high cytokine activity. However, a 1203 (H5N1) virus carrying
WSN (H1N1) PB2, PB1, and PA gene segments also manifested
a high-cytokine phenotype, although the WSN polymerases in
the homologous WSN background did not. Similarly, PB2-
K627E substitution in 1203 affects the cytokine phenotype, al-
though this substitution is not a sole determinant of cytokine
induction. For example, WSN has PB2-K627, although it is a
low-cytokine phenotype virus, and, conversely, some high-cy-
tokine phenotype H5N1 viruses have PB2-E627. Similarly, avian
A/quail/Hong Kong/G1/97-like H9N2 viruses, which induce
high cytokine production in human macrophages, contain glu-
tamic acid at the PB2 627 position. These findings suggest that
PB2-K627 is not a sole determinant of the high-cytokine phe-
notype. Thus, the overall polymerase functionality and its con-
text within the other viral genes all appear to be important in
determining the ability of a virus to induce high cytokine lev-
els in human cells.
Because viral transcription and replication are mainly reg-
ulated by the polymerases, the efficiency of virus replication
may be related to the high-cytokine phenotype. Interestingly,
within the high-cytokine phenotype H5N1 viruses and within
the panel of recombinant viruses we generated, there was sig-
nificant positive correlation between viral gene transcription
(as assessed by virus M gene copy numbers 3 h after infection)
(figure 4A) and TNF-a protein levels 6 h after infection (figures
1A and 2A) ( , by Spearman test). However, when weP ! .05
considered all high- and low-cytokine phenotype wild-type
H1N1 and H5N1 viruses studied here (figure 1A), there was
no significant correlation between virus M gene copy numbers
and TNF-a protein levels. Thus, we conclude that viral repli-
cation competence does not explain the marked differences in
cytokine induction between low pathogenic H1N1 and highly
pathogenic avian influenza H5N1 viruses. However, it does
explain the variability in cytokine induction within the highly
pathogenic avian influenza H5N1 virus group. The 1203(PB2-
K627E) virus has similar virus replication competence in hu-
man macrophages when compared with the 1203 wild-type
virus 1203(PB2-627K) but still has a low-cytokine phenotype.
The pandemics of 1957 and 1968 arose through reassort-
ment, with the prevailing human seasonal influenza virus ac-
quiring HA and PB1 genes (and the NA gene in 1957) from
an avian influenza virus. Our results show that a human H1N1
virus with H5N1 HA, NA, and PB1 genes does not retain the
high-cytokine phenotype. These results have also been repeated
with a different H1N1 virus, A/PR/8/34. Thus, a pandemic virus
that arises through reassortment between H5N1 and contem-
porary seasonal influenza viruses may have an unpredictable
cytokine phenotype. However, we remain cognizant of the fact
that the H5 HA retains virulence properties of its own, irre-
spective of cytokine induction.
Although antiviral drugs remain the mainstay of treatment
for H5N1 disease in humans, an understanding of the patho-
genesis of the disease process may lead to novel adjunctive ther-
apies. This is particularly relevant in view of the poor overall
survival in patients who begin treatment later in the course of
the disease when the immunopathological cascades already ini-
tiated cannot be controlled by antiviral treatment alone [23].
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